TETobias V. Eden

Tobias V. Eden

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tobias V. Eden has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Ashvinath Narenderan

    NUS Synthetic Biology for Clinical and Technological Innovation (SynCTI), National University of Singapore, Singapore, Singapore

    2 shared publications
  • Fabian Willenborg

    NUS Synthetic Biology for Clinical and Technological Innovation (SynCTI), National University of Singapore, Singapore, Singapore

    2 shared publications
  • Julius Fredens

    NUS Synthetic Biology for Clinical and Technological Innovation, Yong Loo Lin School of Medicine, National University of Singapore, and National Centre for Engineering Biology, Singapore, Singapore

    2 shared publications
  • Shujian Ong

    NUS Synthetic Biology for Clinical and Technological Innovation (SynCTI), National University of Singapore, Singapore, Singapore

    2 shared publications
  • Shuxuan Lao

    NUS Synthetic Biology for Clinical and Technological Innovation (SynCTI), National University of Singapore, Singapore, Singapore

    2 shared publications
  • Wen Shan Yew

    Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore (NUS), 8 Medical Drive, Singapore 117597, Singapore

    2 shared publications

Latest Publications

  • Open Access

    Bridging continuous and discrete evolution through a controllable, hypermutagenic phage-bacteria system

    by Shujian Ong, Pramila Ghode, Ashvinath Narenderan, Shuxuan Lao, Fabian Willenborg, Tobias V. Eden, Carl O. Marsh, Wen Shan Yew, Julius Fredens

    Directed evolution methods face trade-offs between the control of discrete approaches and the throughput of modern continuous systems. Here, we engineered a method called lytic selection and evolution (LySE) for near-continuous evolution of bacterial gene clusters while maintaining discrete checkpoints. We developed a hypermutagenic T7 DNA polymerase variant fused to a dual adenine-cytosine deaminase to install all possible transition mutations at similar frequencies. By relieving pressure from maintaining genome fidelity, we obtained mutation rates of 3.82 × 10−5 substitutions per base. For biocontainment, the T7 DNA polymerase was encoded on an accessory plasmid, while the target gene cluster was encoded on a T7 DNA polymerase-lacking T7 phagemid. Alternating cycles of lysis and transduction enable selective replication and mutagenesis of target genes, while off-target genomic mutations are discarded. LySE evolved a 25-fold increase in tetA-encoded tigecycline resistance in 5 cycles, and a 50.9% increase in endpoint biomass of a bacterial strain that uses the polyethylene terephthalate monomer, ethylene glycol, as its sole carbon source. Our method balances speed and control for directed bacterial evolution.


  • Open Access

    Accelerated evolution of whole gene clusters by an engineered lytic phage system in E. coli

    by Shujian Ong, Pramila Ghode, Ashvinath Narenderan, Fabian Willenborg, Tobias V. Eden, Shuxuan Lao, Carl O. Marsh, Wen Shan Yew, Julius Fredens

    Directed evolution excels at optimizing individual proteins, but simultaneous evolution of multiple genes remains a significant challenge. Here, we establish a robust phage-based system for accelerated evolution of large gene clusters of up to 39 kilobases. Lytic Selection and Evolution (LySE) selectively replicates and mutagenizes the target gene cluster, carried on a phagemid through alternating cycles of lysis and transduction in Escherichia coli . We engineered a hypermutagenic T7 DNA polymerase (T7 DNAP) that increases mutation rates of the replicating phagemid 7,000-fold during the lytic cycle. We further optimized the mutational spectrum by fusing the T7 DNAP to a dual adenine-cytosine deaminase to install all possible transition mutations at similar frequencies. LySE-mediated transduction enables selection for desired metabolic functions by coupling gene cluster expression to host fitness, while eliminating genomic off-target mutations by refreshing the host in each cycle. Using LySE, we evolved a 25-fold increase in tigecycline resistance in 5 cycles, and a 50.9% increase in end-point biomass of a bacterial strain that utilizes the PET monomer, ethylene glycol, as its sole carbon source.